The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function

Taipei City Hospital

Status and phase: Completed; Phase 3; Phase 2

Conditions: Liver Function

Treatments: Drug: KSY

Study type: Interventional

Funder types: Other

Identifiers

NCT01708733

101001-62-010

Details and patient eligibility

About

The aim of the study is to examine whether the Chinese herbal formula (KSY) is effective on HCV Carrier With Abnormal Liver Function.

Full description

percentage of change on HCV RNA titer and liver function (GPT).

Enrollment: 57 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 40 < GPT <200 HCV carrier Age: 18-65 yrs old

Exclusion criteria

• Creatinine >2.0 mg/dL Total bilirubin > 2.0mg/dL Not suitable patients diagnosis by physician in charge.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

57 participants in 2 patient groups, including a placebo group

KSY diluted

Placebo Comparator group

Description:

KSY diluted, 100mg decoction by mouth per day for 6 weeks

KSY

Experimental group

Description:

KSY, 100mg decoction by mouth per day for 6 weeks

Treatment:

Drug: KSY